Literature DB >> 6806175

Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials.

E Ribi, D L Granger, K C Milner, K Yamamoto, S M Strain, R Parker, R W Smith, W Brehmer, I Azuma.   

Abstract

Factors contributing to protection against experimental tuberculosis have been studied with refined and well characterized fractions from mycobacteria and with certain unrelated antigens. Mice were vaccinated intravenously with various combinations of materials presented on minute oil droplets in saline emulsions and were later challenged by aerosol. The minimal composition of an effective vaccine was P3 (a trehalose mycolate similar to cord factor) plus an antigen, which could be tuberculoprotein, or a low-molecular-weight tuberculin-active peptide, or unrelated antigen such as bovine serum albumin or bacterial endotoxin. Development of a hypersensitivity granuloma in the lungs appeared to be essential to protection in this laboratory model.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806175      PMCID: PMC1555377     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  [Immunobiology of tuberculosis].

Authors:  P Kallós
Journal:  Naturwissenschaften       Date:  1976-04

2.  Electron microscopically revealed structural elements of Bacterium tularense and their in vitro and in vivo role in immunologic reactions.

Authors:  C C SHEPARD; E RIBI; C LARSON
Journal:  J Immunol       Date:  1955-07       Impact factor: 5.422

3.  Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3.

Authors:  I Azuma; E E Ribi; T J Meyer; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-01       Impact factor: 13.506

4.  Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components.

Authors:  S B Salvin; E Ribi; D L Granger; J S Youngner
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

5.  Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets.

Authors:  D L Granger; K I Yamamoto; E Ribi
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

6.  Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions.

Authors:  A Bekierkunst; E Yarkoni; I Flechner; S Morecki; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

7.  Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity.

Authors:  K S Warren; E O Domingo; R B Cowan
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

8.  Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli.

Authors:  A Bekierkunst; I S Levij; E Yarkoni; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

9.  Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis.

Authors:  K Yamamoto; D L Granger; W Brehmer; I Azuma; E Ribi
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1981

10.  Factors influencing protection against experimental tuberculosis in mice by heat-stable cell wall vaccines.

Authors:  E Ribi; R L Anacker; W Brehmer; G Goode; C L Larson; R H List; K C Milner; W C Wicht
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

View more
  11 in total

1.  Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis.

Authors:  G R Hirschfield; M McNeil; P J Brennan
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

2.  Microbicidal activity and morphological characteristics of lung macrophages in Mycobacterium bovis BCG cell wall-induced lung granuloma in mice.

Authors:  K Kato; K Yamamoto; H Okuyama; T Kimura
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

3.  Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis.

Authors:  V M Lima; V L Bonato; K M Lima; S A Dos Santos; R R Dos Santos; E D Gonçalves; L H Faccioli; I T Brandão; J M Rodrigues-Junior; C L Silva
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  In vivo administration of mycobacterial cord factor (Trehalose 6, 6'-dimycolate) can induce lung and liver granulomas and thymic atrophy in rabbits.

Authors:  N Hamasaki; K Isowa; K Kamada; Y Terano; T Matsumoto; T Arakawa; K Kobayashi; I Yano
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Protective immunity to experimental tuberculosis by mannophosphoinositides of mycobacteria.

Authors:  P K Mehta; G K Khuller
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

Review 6.  Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates.

Authors:  Else Marie Agger
Journal:  Adv Drug Deliv Rev       Date:  2015-11-17       Impact factor: 15.470

7.  Immunological significance of Mycobacterium leprae cell walls.

Authors:  J Melancon-Kaplan; S W Hunter; M McNeil; C Stewart; R L Modlin; T H Rea; J Convit; P Salgame; V Mehra; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Role of the major histocompatibility complex in resistance and granuloma formation in response to Mycobacterium lepraemurium infection.

Authors:  H O Adu; J Curtis; J L Turk
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Immunogenicity of mannophosphoinositides of mycobacteria: effect of cord factor (trehalose-6,6'-dimycolate).

Authors:  P K Mehta; G K Khuller
Journal:  Folia Microbiol (Praha)       Date:  1990       Impact factor: 2.099

Review 10.  Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.